KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Arbutus Biopharma (ABUS) Preferred Shares Issued (2017 - 2018)

Arbutus Biopharma (ABUS) has disclosed Preferred Shares Issued for 2 consecutive years, with $66.3 million as the latest value for Q1 2018.

  • Quarterly Preferred Shares Issued changed N/A to $66.3 million in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $66.3 million through Dec 2018, up 35.6% year-over-year, with the annual reading at $66.3 million for FY2018, 35.6% up from the prior year.
  • Preferred Shares Issued hit $66.3 million in Q1 2018 for Arbutus Biopharma, up from $48.9 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $66.3 million in Q1 2018 to a low of $48.9 million in Q4 2017.